Free Trial

Illumina (ILMN) Financials

Illumina logo
$82.49 +2.12 (+2.64%)
Closing price 05/27/2025 04:00 PM Eastern
Extended Trading
$82.76 +0.28 (+0.33%)
As of 04:18 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for Illumina

Annual Income Statements for Illumina

This table shows Illumina's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/29/2024 12/31/2023 1/1/2023 1/2/2022 1/3/2021 12/29/2019 12/30/2018 12/31/2017 1/1/2017 1/3/2016
Net Income / (Loss) Attributable to Common Shareholders
-1,223 -1,161 -4,404 762 656 1,002 826 726 463 462
Consolidated Net Income / (Loss)
-1,223 -1,161 -4,404 762 656 990 782 678 428 458
Net Income / (Loss) Continuing Operations
-1,223 -1,161 -4,404 762 656 990 782 678 428 458
Total Pre-Tax Income
-1,179 -1,117 -4,336 884 856 1,118 894 1,043 561 583
Total Operating Income
-833 -1,069 -4,179 -123 580 985 883 606 587 613
Total Gross Profit
2,861 2,744 2,972 3,154 2,203 2,467 2,300 1,826 1,666 1,549
Total Revenue
4,372 4,504 4,584 4,526 3,239 3,543 3,333 2,752 2,398 2,220
Operating Revenue
4,372 4,504 4,584 4,526 3,239 3,543 3,333 2,752 2,398 2,220
Total Cost of Revenue
1,511 1,760 1,612 1,372 1,036 1,076 1,033 926 732 671
Operating Cost of Revenue
1,511 1,760 1,612 1,372 1,036 1,076 1,033 926 732 671
Total Operating Expenses
3,694 3,813 7,151 3,277 1,623 1,482 1,417 1,220 1,079 936
Selling, General & Admin Expense
1,092 1,612 1,297 2,092 941 835 794 674 584 516
Research & Development Expense
1,169 1,354 1,321 1,185 682 647 623 546 504 401
Impairment Charge
1,889 827 3,914 0.00 0.00 - - - - -
Other Special Charges / (Income)
-456 20 619 0.00 0.00 - - - -9.00 19
Total Other Income / (Expense), net
-346 -48 -157 1,007 276 133 11 437 -26 -30
Interest Expense
100 77 26 61 49 52 57 37 33 43
Interest & Investment Income
46 58 11 0.00 41 75 44 19 10 21
Other Income / (Expense), net
-292 -29 -142 1,068 284 110 24 455 -3.00 -8.00
Income Tax Expense
44 44 68 122 200 128 112 365 133 125
Basic Earnings per Share
($7.69) ($7.34) ($28.00) $5.07 $4.48 $6.81 $5.63 $4.96 $3.09 $3.19
Weighted Average Basic Shares Outstanding
159M 158M 157M 150M 147M 147M 147M 146M 147M 145M
Diluted Earnings per Share
($7.69) ($7.34) ($28.00) $5.04 $4.45 $6.74 $5.56 $4.92 $3.07 $3.10
Weighted Average Diluted Shares Outstanding
159M 158M 157M 151M 148M 149M 149M 148M 148M 149M
Weighted Average Basic & Diluted Shares Outstanding
158.40M 158.90M 158M 157M 145.90M 147M 146.70M 146.40M 149.80M 144.70M

Quarterly Income Statements for Illumina

This table shows Illumina's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/30/2025 12/29/2024 9/29/2024 6/30/2024 3/31/2024 12/31/2023 10/1/2023 7/2/2023 4/2/2023 1/1/2023 10/2/2022
Net Income / (Loss) Attributable to Common Shareholders
131 186 705 -1,988 -126 -176 -754 -234 3.00 -139 -3,816
Consolidated Net Income / (Loss)
131 186 705 -1,988 -126 -176 -754 -234 3.00 -139 -3,816
Net Income / (Loss) Continuing Operations
131 186 705 -1,988 -126 -176 -754 -234 3.00 -139 -3,816
Total Pre-Tax Income
182 186 720 -1,976 -109 -168 -782 -89 -78 -167 -3,672
Total Operating Income
164 174 741 -1,637 -111 -163 -754 -88 -64 -127 -3,657
Total Gross Profit
683 728 745 721 667 673 684 732 655 673 717
Total Revenue
1,041 1,104 1,080 1,112 1,076 1,122 1,119 1,176 1,087 1,084 1,115
Operating Revenue
1,041 1,104 1,080 1,112 1,076 1,122 1,119 1,176 1,087 1,084 1,115
Total Cost of Revenue
358 376 335 391 409 449 435 444 432 411 398
Operating Cost of Revenue
358 376 335 391 409 449 435 444 432 411 398
Total Operating Expenses
519 554 4.00 2,358 778 836 1,438 820 719 800 4,374
Selling, General & Admin Expense
267 267 239 147 439 469 303 462 378 433 146
Research & Development Expense
252 252 253 325 339 340 315 358 341 346 325
Total Other Income / (Expense), net
18 12 -21 -339 2.00 -5.00 -28 -1.00 -14 -40 -15
Interest Expense
25 26 36 20 18 19 19 19 20 8.00 6.00
Interest & Investment Income
11 10 11 13 12 11 13 17 17 7.00 3.00
Other Income / (Expense), net
32 28 4.00 -332 8.00 3.00 -22 1.00 -11 -39 -12
Income Tax Expense
51 - 15 12 17 8.00 -28 145 -81 -28 144
Basic Earnings per Share
$0.83 $1.17 $4.43 ($12.48) ($0.79) ($1.11) ($4.77) ($1.48) $0.02 ($0.89) ($24.26)
Weighted Average Basic Shares Outstanding
159M 159M 159M 159M 159M 158M 158M 158M 158M 157M 157M
Diluted Earnings per Share
$0.82 $1.17 $4.42 ($12.48) ($0.79) ($1.11) ($4.77) ($1.48) $0.02 ($0.89) ($24.26)
Weighted Average Diluted Shares Outstanding
159M 159M 160M 159M 159M 158M 158M 158M 158M 157M 157M
Weighted Average Basic & Diluted Shares Outstanding
158.30M 158.40M 158.60M 159.30M 159.30M 158.90M 158.80M 158.30M 158.10M 158M 157.30M

Annual Cash Flow Statements for Illumina

This table details how cash moves in and out of Illumina's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/29/2024 12/31/2023 1/1/2023 1/2/2022 1/3/2021 12/29/2019 12/30/2018 12/31/2017 1/1/2017 1/3/2016
Net Change in Cash & Equivalents
79 -963 779 -578 -232 898 -77 490 -34 133
Net Cash From Operating Activities
837 478 392 545 1,080 1,051 1,142 875 779 786
Net Cash From Continuing Operating Activities
837 478 392 545 1,080 1,051 1,142 875 779 786
Net Income / (Loss) Continuing Operations
-1,223 -1,161 -4,404 762 656 990 782 678 428 458
Consolidated Net Income / (Loss)
-1,223 -1,161 -4,404 762 656 990 782 678 428 458
Depreciation Expense
224 235 215 176 156 151 140 110 90 73
Amortization Expense
130 197 179 107 71 83 80 76 81 93
Non-Cash Adjustments To Reconcile Net Income
2,616 1,354 4,426 -276 7.00 10 176 -265 131 121
Changes in Operating Assets and Liabilities, net
-910 -147 -24 -224 190 -183 -36 276 49 41
Net Cash From Investing Activities
-178 -231 -591 -1,069 -554 745 -1,813 -214 -515 -107
Net Cash From Continuing Investing Activities
-178 -231 -591 -1,069 -554 745 -1,813 -214 -515 -107
Purchase of Property, Plant & Equipment
-128 -195 -286 -208 -189 -209 -296 -310 -260 -143
Acquisitions
-81 -30 -265 -2,444 -98 -29 -100 -2.00 -29 -37
Purchase of Investments
-52 -6.00 -40 221 -2,058 -1,048 -2,859 -742 -895 -797
Divestitures
83 0.00 0.00 - - 15 0.00 278 0.00 0.00
Net Cash From Financing Activities
-570 -1,210 1,000 -51 -766 -897 594 -176 -296 -545
Net Cash From Continuing Financing Activities
-570 -1,210 1,000 -51 -766 -897 594 -176 -296 -545
Repayment of Debt
-750 -1,236 0.00 -517 0.00 -550 -4.00 -9.00 -66 -245
Repurchase of Common Equity
-116 0.00 0.00 - -736 -324 -201 -251 -249 -274
Payment of Dividends
-1.00 -1.00 0.00 - - - - -3.00 -29 -3.00
Issuance of Debt
1,241 0.00 991 988 0.00 0.00 735 5.00 5.00 0.00
Issuance of Common Equity
56 67 63 60 61 59 138 150 136 104
Other Financing Activities, net
-1,000 -40 -54 -582 -91 -82 -74 -68 -93 -127
Effect of Exchange Rate Changes
-10 0.00 -22 -3.00 8.00 -1.00 - - -2.00 -1.00
Cash Interest Paid
83 73 17 9.00 - - - - - -
Cash Income Taxes Paid
105 65 122 233 119 164 99 149 60 17

Quarterly Cash Flow Statements for Illumina

This table details how cash moves in and out of Illumina's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/30/2025 12/29/2024 9/29/2024 6/30/2024 3/31/2024 12/31/2023 10/1/2023 7/2/2023 4/2/2023 1/1/2023 10/2/2022
Net Change in Cash & Equivalents
-14 258 -51 -188 60 121 -626 59 -517 1,011 -289
Net Cash From Operating Activities
240 364 316 80 77 224 139 105 10 147 -52
Net Cash From Continuing Operating Activities
240 364 316 80 77 224 139 105 10 147 -52
Net Income / (Loss) Continuing Operations
131 187 704 -1,988 -126 -175 -755 -234 3.00 -139 -3,816
Consolidated Net Income / (Loss)
131 187 704 -1,988 -126 -175 -755 -234 3.00 -139 -3,816
Depreciation Expense
52 54 54 57 59 60 59 59 57 57 56
Amortization Expense
17 17 16 48 49 49 49 49 50 49 47
Non-Cash Adjustments To Reconcile Net Income
39 66 113 2,308 129 145 973 128 108 152 4,008
Changes in Operating Assets and Liabilities, net
1.00 40 -571 -345 -34 145 -187 103 -208 28 -347
Net Cash From Investing Activities
-63 -48 -41 -41 -48 -85 -53 -37 -56 -102 -250
Net Cash From Continuing Investing Activities
-63 -48 -41 -41 -48 -85 -53 -37 -56 -102 -250
Purchase of Property, Plant & Equipment
-32 -29 -32 -31 -36 -51 -45 -47 -52 -88 -66
Acquisitions
-7.00 - -81 - 0.00 -29 - - -1.00 - -180
Purchase of Investments
-24 -19 -11 -10 -12 -5.00 10 -8.00 -3.00 -14 -4.00
Net Cash From Financing Activities
-195 -47 -332 -226 35 -27 -707 -3.00 -473 956 28
Net Cash From Continuing Financing Activities
-195 -47 -332 -226 35 -27 -707 -3.00 -473 956 28
Repurchase of Common Equity
-200 -17 - - - - - - - - -
Issuance of Common Equity
27 - 20 - 36 - 30 - 37 - 30
Other Financing Activities, net
-22 -30 - -969 -1.00 -26 -2.00 -3.00 -9.00 -35 -2.00
Effect of Exchange Rate Changes
4.00 -11 6.00 -1.00 -4.00 9.00 -5.00 - - 10 -15

Annual Balance Sheets for Illumina

This table presents Illumina's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/29/2024 12/31/2023 1/1/2023 1/2/2022 1/3/2021 12/29/2019 12/30/2018 12/31/2017 1/1/2017 1/3/2016
Total Assets
6,303 10,111 12,252 15,217 7,585 7,316 6,959 5,257 4,281 3,688
Total Current Assets
2,746 2,609 3,561 2,713 4,483 4,451 4,490 2,980 2,318 2,097
Cash & Equivalents
1,127 1,048 2,011 1,232 1,810 2,042 1,144 1,225 735 769
Short-Term Investments
93 6.00 26 107 1,662 1,372 2,368 920 824 617
Accounts Receivable
735 734 671 648 487 573 514 411 381 386
Inventories, net
547 587 568 431 372 359 386 333 300 271
Prepaid Expenses
244 234 285 295 152 105 78 91 78 54
Plant, Property, & Equipment, net
815 1,007 1,091 1,024 922 889 1,075 931 713 343
Total Noncurrent Assets
2,742 6,495 7,600 11,480 2,180 1,976 1,394 1,346 1,250 1,248
Goodwill
1,113 2,545 3,239 7,113 897 824 831 771 776 753
Intangible Assets
295 2,993 3,285 3,250 142 145 185 175 243 274
Noncurrent Deferred & Refundable Income Taxes
567 56 - - - 64 70 88 123 135
Other Noncurrent Operating Assets
767 901 1,076 1,117 1,141 943 308 312 108 87
Total Liabilities & Shareholders' Equity
6,303 10,111 12,252 15,217 7,585 7,316 6,959 5,257 4,281 3,688
Total Liabilities
3,930 4,366 5,653 4,477 2,891 2,703 3,053 2,288 1,967 1,807
Total Current Liabilities
1,547 1,570 2,773 1,093 1,244 665 1,804 746 705 610
Short-Term Debt
499 0.00 1,248 0.00 511 0.00 1,107 10 2.00 75
Accounts Payable
221 245 293 332 192 149 184 160 138 139
Accrued Expenses
827 1,325 1,232 761 541 516 513 432 342 387
Total Noncurrent Liabilities
2,383 2,796 2,880 3,384 1,647 2,038 1,249 1,542 1,262 1,196
Long-Term Debt
1,490 1,489 1,487 1,695 673 1,141 890 1,182 1,056 1,016
Other Noncurrent Operating Liabilities
893 1,307 1,393 1,689 974 897 359 360 206 181
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
2,373 5,745 6,599 10,740 4,694 4,613 3,845 2,749 2,270 1,849
Total Preferred & Common Equity
2,373 5,745 6,599 10,740 4,694 4,613 3,758 2,749 2,197 1,849
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
2,373 5,745 6,599 10,740 4,694 4,613 3,758 2,749 2,197 1,849
Common Stock
7,527 9,557 9,209 8,940 3,817 3,562 3,292 2,835 2,735 2,499
Retained Earnings
-1,242 -19 1,142 5,485 4,723 4,067 3,083 2,256 1,485 1,023
Treasury Stock
-3,934 -3,792 -3,755 -3,702 -3,848 -3,021 -2,616 -2,341 -2,022 -1,674
Accumulated Other Comprehensive Income / (Loss)
22 -1.00 3.00 17 2.00 5.00 -1.00 -1.00 -1.00 0.04

Quarterly Balance Sheets for Illumina

This table presents Illumina's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/30/2025 12/29/2024 9/29/2024 6/30/2024 3/31/2024 12/31/2023 10/1/2023 7/2/2023 4/2/2023 1/1/2023 10/2/2022
Total Assets
6,182 6,303 6,014 6,081 10,040 10,111 10,122 11,774 11,811 12,252 11,256
Total Current Assets
2,673 2,746 2,373 2,459 2,583 2,609 2,506 3,223 3,172 3,561 2,487
Cash & Equivalents
1,113 1,127 869 920 1,108 1,048 927 1,553 1,494 2,011 1,000
Short-Term Investments
124 93 70 74 - 6.00 6.00 6.00 24 26 41
Accounts Receivable
699 735 699 641 635 734 690 741 665 671 628
Inventories, net
537 547 574 561 584 587 615 617 586 568 559
Prepaid Expenses
200 244 161 263 256 234 268 306 403 285 259
Plant, Property, & Equipment, net
782 815 832 859 964 1,007 1,040 1,069 1,082 1,091 1,068
Total Noncurrent Assets
2,727 2,742 2,809 2,763 6,493 6,495 6,576 7,482 7,557 7,600 7,701
Goodwill
1,113 1,113 1,113 1,079 2,545 2,545 2,527 3,239 3,239 3,239 3,238
Intangible Assets
278 295 305 278 2,940 2,993 3,029 3,188 3,237 3,285 3,335
Noncurrent Deferred & Refundable Income Taxes
553 567 617 632 - 56 - - - - -
Other Noncurrent Operating Assets
783 767 774 774 1,008 901 1,020 1,055 1,081 1,076 1,128
Total Liabilities & Shareholders' Equity
6,182 6,303 6,014 6,081 10,040 10,111 10,122 11,774 11,811 12,252 11,256
Total Liabilities
3,814 3,930 3,889 4,645 4,306 4,366 4,224 5,219 5,118 5,653 4,525
Total Current Liabilities
1,440 1,547 975 2,208 1,474 1,570 1,482 2,303 2,230 2,773 2,669
Short-Term Debt
499 499 - 744 - 0.00 0.00 750 749 1,248 1,246
Accounts Payable
207 221 191 199 201 245 240 244 242 293 281
Accrued Expenses
734 827 784 1,265 1,273 1,325 1,242 1,309 1,239 1,232 1,142
Total Noncurrent Liabilities
2,374 2,383 2,914 2,437 2,832 2,796 2,742 2,916 2,888 2,880 1,856
Long-Term Debt
1,491 1,490 1,988 1,490 1,490 1,489 1,489 1,488 1,487 1,487 495
Other Noncurrent Operating Liabilities
883 893 926 947 1,342 1,307 1,253 1,428 1,401 1,393 1,361
Total Equity & Noncontrolling Interests
2,368 2,373 2,125 1,436 5,734 5,745 5,898 6,555 6,693 6,599 6,731
Total Preferred & Common Equity
2,368 2,373 2,125 1,436 5,734 5,745 5,898 6,555 6,693 6,599 6,731
Total Common Equity
2,368 2,373 2,125 1,436 5,734 5,745 5,898 6,555 6,693 6,599 6,731
Common Stock
7,610 7,527 7,451 7,349 9,660 9,557 9,489 9,399 9,313 9,209 9,131
Retained Earnings
-1,111 -1,242 -1,428 -2,133 -145 -19 157 911 1,145 1,142 1,281
Treasury Stock
-4,139 -3,934 -3,893 - -3,793 -3,792 -3,769 -3,767 -3,764 -3,755 -3,720
Accumulated Other Comprehensive Income / (Loss)
8.00 22 -5.00 14 12 -1.00 21 12 -1.00 3.00 39

Annual Metrics And Ratios for Illumina

This table displays calculated financial ratios and metrics derived from Illumina's official financial filings.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/29/2024 12/31/2023 1/1/2023 1/2/2022 1/3/2021 12/29/2019 12/30/2018 12/31/2017 1/1/2017 1/3/2016
Growth Metrics
- - - - - - - - - -
Revenue Growth
-2.93% -1.75% 1.28% 39.73% -8.58% 6.30% 21.11% 14.76% 8.02% 19.27%
EBITDA Growth
-15.77% 83.04% -419.79% 12.56% -17.91% 17.92% -9.62% 65.17% -2.08% 21.84%
EBIT Growth
-2.46% 74.59% -557.25% 9.38% -21.10% 20.73% -14.51% 81.68% -3.47% 25.48%
NOPAT Growth
22.08% 74.42% -2,659.07% -123.85% -49.04% 12.93% 96.07% -12.04% -7.00% 18.82%
Net Income Growth
-5.34% 73.64% -677.95% 16.16% -33.74% 26.60% 15.34% 58.41% -6.55% 29.62%
EPS Growth
-4.77% 73.64% -677.95% 13.26% -33.98% 21.22% 13.01% 60.26% -0.97% 30.80%
Operating Cash Flow Growth
75.10% 21.94% -28.07% -49.54% 2.76% -7.97% 30.51% 12.32% -0.89% 56.80%
Free Cash Flow Firm Growth
565.83% -57.80% 109.93% -2,424.00% -59.00% 132.33% 108.13% -13.33% 15.28% -44.89%
Invested Capital Growth
-49.16% -15.31% -34.24% 361.18% 2.82% -2.13% 18.60% 11.20% 14.35% 22.43%
Revenue Q/Q Growth
-0.41% 0.85% -2.45% 5.75% 0.03% -13.31% 27.46% 6.13% 1.15% 3.71%
EBITDA Q/Q Growth
29.59% 1.33% -6.97% -11.78% 3.90% 3.02% 0.45% 7.87% -0.20% -6.86%
EBIT Q/Q Growth
24.34% 0.54% -6.59% -17.32% 4.22% 4.68% -1.52% 9.38% -0.84% -8.92%
NOPAT Q/Q Growth
28.80% -3.49% -4.21% -300.08% -19.42% 6.50% 19.20% -0.50% 0.79% -9.62%
Net Income Q/Q Growth
22.84% -3.29% -6.07% -15.89% 2.82% 4.43% 21.62% -6.74% 0.83% -9.81%
EPS Q/Q Growth
22.87% -3.29% -6.07% -15.44% 3.49% 2.90% 20.61% -6.11% 2.68% -9.62%
Operating Cash Flow Q/Q Growth
20.09% 19.20% -25.62% -18.54% -3.31% 15.75% 0.53% 3.80% -11.86% 40.42%
Free Cash Flow Firm Q/Q Growth
-0.25% 45.21% 12.45% -3.57% -6.91% 14.69% 5.14% 44.87% -3.32% 7.80%
Invested Capital Q/Q Growth
-1.01% -4.25% -1.80% 0.74% -5.61% -2.66% 0.04% -4.91% -2.31% -3.29%
Profitability Metrics
- - - - - - - - - -
Gross Margin
65.44% 60.92% 64.83% 69.69% 68.01% 69.63% 69.01% 66.35% 69.47% 69.77%
EBITDA Margin
-17.63% -14.79% -85.67% 27.13% 33.68% 37.51% 33.81% 45.31% 31.48% 34.73%
Operating Margin
-19.05% -23.73% -91.16% -2.72% 17.91% 27.80% 26.49% 22.02% 24.48% 27.61%
EBIT Margin
-25.73% -24.38% -94.26% 20.88% 26.67% 30.91% 27.21% 38.55% 24.35% 27.25%
Profit (Net Income) Margin
-27.97% -25.78% -96.07% 16.84% 20.25% 27.94% 23.46% 24.64% 17.85% 20.63%
Tax Burden Percent
103.73% 103.94% 101.57% 86.20% 76.64% 88.55% 87.47% 65.00% 76.29% 78.56%
Interest Burden Percent
104.80% 101.73% 100.35% 93.55% 99.07% 102.10% 98.57% 98.30% 96.06% 96.36%
Effective Tax Rate
0.00% 0.00% 0.00% 13.80% 23.36% 11.45% 12.53% 35.00% 23.71% 21.44%
Return on Invested Capital (ROIC)
-12.51% -11.10% -31.81% -1.57% 18.73% 36.87% 35.05% 20.58% 26.36% 33.44%
ROIC Less NNEP Spread (ROIC-NNEP)
-118.81% -83.96% -312.40% -91.43% 9.46% 30.65% 34.27% -18.50% 31.34% 30.68%
Return on Net Nonoperating Assets (RNNOA)
-17.62% -7.71% -18.99% 11.44% -4.63% -13.63% -12.30% 5.09% -5.95% 44.79%
Return on Equity (ROE)
-30.13% -18.81% -50.80% 9.87% 14.10% 23.24% 22.75% 25.67% 20.40% 78.23%
Cash Return on Invested Capital (CROIC)
52.67% 5.47% 9.50% -130.29% 15.95% 39.03% 18.03% 9.97% 12.96% 13.27%
Operating Return on Assets (OROA)
-13.71% -9.82% -31.46% 8.29% 11.60% 15.34% 14.85% 22.25% 14.66% 17.22%
Return on Assets (ROA)
-14.90% -10.38% -32.07% 6.68% 8.80% 13.87% 12.80% 14.22% 10.74% 13.03%
Return on Common Equity (ROCE)
-30.13% -18.81% -50.80% 9.87% 14.10% 22.84% 21.53% 24.03% 19.68% 76.05%
Return on Equity Simple (ROE_SIMPLE)
-51.54% -20.21% -66.74% 7.10% 13.98% 21.46% 20.81% 24.66% 19.48% 24.78%
Net Operating Profit after Tax (NOPAT)
-583 -748 -2,925 -106 444 872 772 394 448 482
NOPAT Margin
-13.34% -16.61% -63.82% -2.34% 13.72% 24.62% 23.17% 14.31% 18.68% 21.69%
Net Nonoperating Expense Percent (NNEP)
106.30% 72.85% 280.59% 89.86% 9.27% 6.22% 0.78% 39.07% -4.98% 2.76%
Return On Investment Capital (ROIC_SIMPLE)
-13.37% -10.34% -31.34% - - - - - - -
Cost of Revenue to Revenue
34.56% 39.08% 35.17% 30.31% 31.99% 30.37% 30.99% 33.65% 30.53% 30.23%
SG&A Expenses to Revenue
24.98% 35.79% 28.29% 46.22% 29.05% 23.57% 23.82% 24.49% 24.35% 23.24%
R&D to Revenue
26.74% 30.06% 28.82% 26.18% 21.06% 18.26% 18.69% 19.84% 21.02% 18.06%
Operating Expenses to Revenue
84.49% 84.66% 156.00% 72.40% 50.11% 41.83% 42.51% 44.33% 45.00% 42.16%
Earnings before Interest and Taxes (EBIT)
-1,125 -1,098 -4,321 945 864 1,095 907 1,061 584 605
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-771 -666 -3,927 1,228 1,091 1,329 1,127 1,247 755 771
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
9.04 3.85 4.82 5.54 11.51 10.59 11.67 11.60 8.56 15.20
Price to Tangible Book Value (P/TBV)
22.23 106.82 424.08 157.73 14.78 13.40 15.99 17.69 15.97 34.17
Price to Revenue (P/Rev)
4.91 4.91 6.94 13.14 16.68 13.79 13.15 11.59 7.84 12.66
Price to Earnings (P/E)
0.00 0.00 0.00 78.04 82.35 48.75 53.07 43.94 40.62 60.82
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 1.28% 1.21% 2.05% 1.88% 2.28% 2.46% 1.64%
Enterprise Value to Invested Capital (EV/IC)
7.07 3.65 4.45 5.39 21.50 19.90 17.76 15.46 10.16 17.56
Enterprise Value to Revenue (EV/Rev)
5.08 5.01 7.09 13.22 15.97 13.15 12.74 11.33 7.68 12.54
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 48.71 47.42 35.04 37.69 24.99 24.40 36.11
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 63.30 59.88 42.53 46.83 29.37 31.55 46.01
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 116.39 53.40 54.99 79.12 41.14 57.81
Enterprise Value to Operating Cash Flow (EV/OCF)
26.55 47.17 82.92 109.76 47.90 44.31 37.19 35.62 23.65 35.42
Enterprise Value to Free Cash Flow (EV/FCFF)
9.05 61.15 37.20 0.00 136.68 50.45 106.88 163.24 83.64 145.67
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
0.84 0.26 0.41 0.16 0.25 0.25 0.51 0.40 0.46 0.58
Long-Term Debt to Equity
0.63 0.26 0.23 0.16 0.14 0.25 0.23 0.40 0.46 0.54
Financial Leverage
0.15 0.09 0.06 -0.13 -0.49 -0.44 -0.36 -0.28 -0.19 1.46
Leverage Ratio
2.02 1.81 1.58 1.48 1.60 1.68 1.78 1.81 1.90 6.00
Compound Leverage Factor
2.12 1.84 1.59 1.38 1.59 1.71 1.75 1.77 1.82 5.78
Debt to Total Capital
45.60% 20.58% 29.30% 13.63% 20.14% 19.83% 33.83% 28.65% 31.38% 36.70%
Short-Term Debt to Total Capital
11.44% 0.00% 13.37% 0.00% 8.69% 0.00% 18.75% 0.24% 0.06% 2.52%
Long-Term Debt to Total Capital
34.16% 20.58% 15.93% 13.63% 11.45% 19.83% 15.08% 28.41% 31.32% 34.18%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 2.51% 5.29% 3.47% 1.10%
Common Equity to Total Capital
54.40% 79.42% 70.70% 86.37% 79.86% 80.17% 63.66% 66.07% 65.15% 62.21%
Debt to EBITDA
-2.58 -2.24 -0.70 1.38 1.09 0.86 1.77 0.96 1.40 1.41
Net Debt to EBITDA
-1.00 -0.65 -0.18 0.29 -2.10 -1.71 -1.34 -0.76 -0.66 -0.38
Long-Term Debt to EBITDA
-1.93 -2.24 -0.38 1.38 0.62 0.86 0.79 0.95 1.40 1.32
Debt to NOPAT
-3.41 -1.99 -0.93 -15.99 2.66 1.31 2.59 3.03 2.36 2.26
Net Debt to NOPAT
-1.32 -0.58 -0.24 -3.36 -5.15 -2.61 -1.96 -2.42 -1.12 -0.61
Long-Term Debt to NOPAT
-2.56 -1.99 -0.51 -15.99 1.51 1.31 1.15 3.00 2.36 2.11
Altman Z-Score
3.33 3.25 2.79 9.10 13.40 13.22 10.61 10.67 7.69 11.35
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 1.74% 5.35% 6.38% 3.56% 2.78%
Liquidity Ratios
- - - - - - - - - -
Current Ratio
1.78 1.66 1.28 2.48 3.60 6.69 2.49 3.99 3.29 3.43
Quick Ratio
1.26 1.14 0.98 1.82 3.18 6.00 2.23 3.43 2.75 2.90
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
2,455 369 874 -8,796 378 923 397 191 220 191
Operating Cash Flow to CapEx
653.91% 245.13% 137.06% 262.02% 571.43% 502.87% 385.81% 282.26% 299.62% 549.65%
Free Cash Flow to Firm to Interest Expense
24.55 4.79 33.60 -144.20 7.72 17.75 6.97 5.16 6.68 4.44
Operating Cash Flow to Interest Expense
8.37 6.21 15.08 8.93 22.04 20.21 20.04 23.65 23.61 18.28
Operating Cash Flow Less CapEx to Interest Expense
7.09 3.68 4.08 5.52 18.18 16.19 14.84 15.27 15.73 14.95
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
0.53 0.40 0.33 0.40 0.43 0.50 0.55 0.58 0.60 0.63
Accounts Receivable Turnover
5.95 6.41 6.95 7.98 6.11 6.52 7.21 6.95 6.26 6.58
Inventory Turnover
2.66 3.05 3.23 3.42 2.83 2.89 2.87 2.93 2.56 2.91
Fixed Asset Turnover
4.80 4.29 4.33 4.65 3.58 3.61 3.32 3.35 4.54 7.30
Accounts Payable Turnover
6.49 6.54 5.16 5.24 6.08 6.46 6.01 6.21 5.28 6.05
Days Sales Outstanding (DSO)
61.32 56.93 52.51 45.77 59.73 55.99 50.65 52.52 58.34 55.49
Days Inventory Outstanding (DIO)
136.97 119.77 113.10 106.81 128.77 126.36 127.03 124.75 142.30 125.63
Days Payable Outstanding (DPO)
56.28 55.79 70.76 69.70 60.07 56.48 60.77 58.73 69.12 60.34
Cash Conversion Cycle (CCC)
142.00 120.91 94.85 82.88 128.43 125.87 116.90 118.55 131.52 120.78
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
3,142 6,180 7,297 11,096 2,406 2,340 2,391 2,016 1,813 1,585
Invested Capital Turnover
0.94 0.67 0.50 0.67 1.36 1.50 1.51 1.44 1.41 1.54
Increase / (Decrease) in Invested Capital
-3,038 -1,117 -3,799 8,690 66 -51 375 203 228 290
Enterprise Value (EV)
22,223 22,546 32,504 59,819 51,732 46,574 42,473 31,167 18,425 27,838
Market Capitalization
21,454 22,111 31,806 59,463 54,020 48,847 43,840 31,900 18,809 28,101
Book Value per Share
$14.96 $36.18 $41.95 $68.71 $32.15 $31.38 $25.56 $18.83 $14.96 $12.63
Tangible Book Value per Share
$6.08 $1.30 $0.48 $2.41 $25.03 $24.79 $18.65 $12.35 $8.02 $5.62
Total Capital
4,362 7,234 9,334 12,435 5,878 5,754 5,903 4,161 3,372 2,972
Total Debt
1,989 1,489 2,735 1,695 1,184 1,141 1,997 1,192 1,058 1,091
Total Long-Term Debt
1,490 1,489 1,487 1,695 673 1,141 890 1,182 1,056 1,016
Net Debt
769 435 698 356 -2,288 -2,273 -1,515 -953 -501 -296
Capital Expenditures (CapEx)
128 195 286 208 189 209 296 310 260 143
Debt-free, Cash-free Net Working Capital (DFCFNWC)
478 -15 -1.00 281 278 372 281 99 56 175
Debt-free Net Working Capital (DFNWC)
1,698 1,039 2,036 1,620 3,750 3,786 3,793 2,244 1,615 1,561
Net Working Capital (NWC)
1,199 1,039 788 1,620 3,239 3,786 2,686 2,234 1,613 1,486
Net Nonoperating Expense (NNE)
640 413 1,479 -868 -212 -118 -9.62 -284 20 24
Net Nonoperating Obligations (NNO)
769 435 698 356 -2,288 -2,273 -1,515 -953 -501 -296
Total Depreciation and Amortization (D&A)
354 432 394 283 227 234 220 186 171 166
Debt-free, Cash-free Net Working Capital to Revenue
10.93% -0.33% -0.02% 6.21% 8.58% 10.50% 8.43% 3.60% 2.34% 7.88%
Debt-free Net Working Capital to Revenue
38.84% 23.07% 44.42% 35.79% 115.78% 106.86% 113.80% 81.54% 67.35% 70.33%
Net Working Capital to Revenue
27.42% 23.07% 17.19% 35.79% 100.00% 106.86% 80.59% 81.18% 67.26% 66.95%
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
($7.69) ($7.13) ($27.21) $4.93 $4.35 $6.62 $5.47 $4.82 $3.00 $3.10
Adjusted Weighted Average Basic Shares Outstanding
159M 162.58M 161.55M 154.35M 151.26M 151.26M 151.26M 150.23M 151.04M 149.02M
Adjusted Diluted Earnings per Share
($7.69) ($7.13) ($27.21) $4.90 $4.32 $6.55 $5.40 $4.78 $2.98 $3.01
Adjusted Weighted Average Diluted Shares Outstanding
159M 162.58M 161.55M 155.38M 152.29M 153.32M 153.32M 152.29M 152.33M 153.39M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $6.62 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
158.40M 163.51M 162.58M 161.55M 150.13M 151.26M 151.26M 151.26M 150.54M 151.26M
Normalized Net Operating Profit after Tax (NOPAT)
420 -155 248 -106 444 872 772 394 441 496
Normalized NOPAT Margin
9.61% -3.45% 5.41% -2.34% 13.72% 24.62% 23.17% 14.31% 18.39% 22.36%
Pre Tax Income Margin
-26.97% -24.80% -94.59% 19.53% 26.43% 31.56% 26.82% 37.90% 23.39% 26.26%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
-11.25 -14.26 -166.19 15.49 17.63 21.06 15.91 28.68 17.70 14.07
NOPAT to Interest Expense
-5.83 -9.72 -112.51 -1.74 9.07 16.77 13.55 10.65 13.57 11.20
EBIT Less CapEx to Interest Expense
-12.53 -16.79 -177.19 12.08 13.78 17.04 10.72 20.30 9.82 10.74
NOPAT Less CapEx to Interest Expense
-7.11 -12.25 -123.51 -5.15 5.21 12.75 8.36 2.27 5.69 7.87
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
-0.08% -0.09% 0.00% 0.00% 0.00% 0.00% 0.00% 0.44% 6.78% 0.66%
Augmented Payout Ratio
-9.57% -0.09% 0.00% 0.00% 112.20% 32.73% 25.70% 37.46% 64.95% 60.48%

Quarterly Metrics And Ratios for Illumina

This table displays calculated financial ratios and metrics derived from Illumina's official financial filings.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/30/2025 12/29/2024 9/29/2024 6/30/2024 3/31/2024 12/31/2023 10/1/2023 7/2/2023 4/2/2023 1/1/2023 10/2/2022
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-3.25% -1.60% -3.49% -5.44% -1.01% 3.51% 0.36% 1.20% -11.12% -9.59% 0.63%
EBITDA Growth
5,200.00% 635.29% 222.01% -8,976.19% -84.38% 15.00% 81.27% 103.90% -86.50% -130.61% -804.74%
EBIT Growth
290.29% 226.25% 196.01% -2,163.22% -37.33% 3.61% 78.85% 86.23% -151.37% -264.36% -945.39%
NOPAT Growth
251.92% 252.50% 237.47% -1,760.23% -73.44% -28.35% 79.38% 84.80% -139.64% -264.84% -522.32%
Net Income Growth
203.97% 205.68% 193.50% -749.57% -4,300.00% -26.62% 80.24% 56.26% -96.51% -223.01% -1,303.79%
EPS Growth
203.80% 205.41% 192.66% -743.24% -4,050.00% -26.62% 80.24% 56.26% -96.36% -223.01% -1,266.35%
Operating Cash Flow Growth
211.69% 62.50% 127.34% -23.81% 670.00% 52.38% 367.31% -16.00% -94.19% -47.87% 80.88%
Free Cash Flow Firm Growth
155.73% 220.27% 791.71% -4.19% -67.65% -72.97% -56.14% 140.99% 143.49% 142.96% 111.54%
Invested Capital Growth
-48.97% -49.16% -50.82% -63.01% -17.47% -15.31% -13.15% -33.37% -33.94% -34.24% -32.54%
Revenue Q/Q Growth
-5.71% 2.22% -2.88% 3.35% -4.10% 0.27% -4.85% 8.19% 0.28% -2.78% -4.04%
EBITDA Q/Q Growth
-2.93% -66.50% 143.72% -37,380.00% 109.80% 92.37% -3,280.95% -34.38% 153.33% 98.32% -562.83%
EBIT Q/Q Growth
-2.97% -72.89% 137.84% -1,811.65% 35.63% 79.38% -791.95% -16.00% 54.82% 95.48% -480.54%
NOPAT Q/Q Growth
-32.16% -76.02% 163.32% -1,374.77% 31.90% 78.38% -756.82% -37.50% 49.61% 96.53% -531.61%
Net Income Q/Q Growth
-29.57% -73.62% 135.46% -1,477.78% 28.41% 76.66% -222.22% -7,900.00% 102.16% 96.36% -613.27%
EPS Q/Q Growth
-29.91% -73.53% 135.42% -1,479.75% 28.83% 76.66% -222.22% -7,900.00% 102.25% 96.36% -613.53%
Operating Cash Flow Q/Q Growth
-34.07% 15.19% 295.00% 3.90% -65.63% 61.15% 32.38% 950.00% -93.20% 382.69% -141.60%
Free Cash Flow Firm Q/Q Growth
-3.08% -19.81% 17.39% 180.30% 21.38% 123.26% -87.39% -5.36% 1.43% 262.28% 111.79%
Invested Capital Q/Q Growth
-0.67% -1.01% 18.61% -56.25% -1.04% -4.25% -10.78% -2.39% 1.56% -1.80% -31.56%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
65.61% 65.94% 68.98% 64.84% 61.99% 59.98% 61.13% 62.24% 60.26% 62.08% 64.30%
EBITDA Margin
25.46% 24.73% 75.46% -167.63% 0.46% -4.55% -59.70% 1.79% 2.94% -5.54% -319.82%
Operating Margin
15.75% 15.76% 68.61% -147.21% -10.32% -14.53% -67.38% -7.48% -5.89% -11.72% -327.98%
EBIT Margin
18.83% 18.30% 68.98% -177.07% -9.57% -14.26% -69.35% -7.40% -6.90% -15.31% -329.06%
Profit (Net Income) Margin
12.58% 16.85% 65.28% -178.78% -11.71% -15.69% -67.38% -19.90% 0.28% -12.82% -342.24%
Tax Burden Percent
71.98% 100.00% 97.92% 100.61% 115.60% 104.76% 96.42% 262.92% -3.85% 83.23% 103.92%
Interest Burden Percent
92.86% 92.08% 96.64% 100.36% 105.83% 105.00% 100.77% 102.30% 104.00% 100.60% 100.08%
Effective Tax Rate
28.02% 0.00% 2.08% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
10.65% 14.78% 61.26% -92.11% -4.80% -6.80% -30.34% -2.58% -1.97% -4.09% -116.97%
ROIC Less NNEP Spread (ROIC-NNEP)
12.93% 16.78% 58.70% -179.87% -13.58% -17.72% -66.36% -34.16% 7.21% -13.59% -340.88%
Return on Net Nonoperating Assets (RNNOA)
1.81% 2.49% 11.74% -43.20% -1.20% -1.63% -6.60% -2.19% 0.43% -0.83% -22.08%
Return on Equity (ROE)
12.46% 17.27% 73.01% -135.31% -6.00% -8.42% -36.94% -4.78% -1.54% -4.91% -139.05%
Cash Return on Invested Capital (CROIC)
56.39% 52.67% 51.12% 54.34% 7.60% 5.47% 3.66% 9.59% 7.61% 9.50% 8.42%
Operating Return on Assets (OROA)
10.07% 9.75% 37.53% -87.84% -3.94% -5.74% -28.97% -2.43% -2.27% -5.11% -117.50%
Return on Assets (ROA)
6.73% 8.98% 35.52% -88.69% -4.82% -6.32% -28.15% -6.52% 0.09% -4.28% -122.21%
Return on Common Equity (ROCE)
12.46% 17.27% 73.01% -135.31% -6.00% -8.42% -36.94% -4.78% -1.54% -4.91% -139.05%
Return on Equity Simple (ROE_SIMPLE)
-40.79% 0.00% -74.59% -211.98% -22.50% 0.00% -19.06% -63.86% -67.04% 0.00% -61.68%
Net Operating Profit after Tax (NOPAT)
118 174 726 -1,146 -78 -114 -528 -62 -45 -89 -2,560
NOPAT Margin
11.34% 15.76% 67.18% -103.05% -7.22% -10.17% -47.17% -5.24% -4.12% -8.20% -229.59%
Net Nonoperating Expense Percent (NNEP)
-2.28% -1.99% 2.56% 87.76% 8.78% 10.93% 36.02% 31.58% -9.17% 9.51% 223.90%
Return On Investment Capital (ROIC_SIMPLE)
2.71% 3.99% - - - -1.58% - - - -0.95% -
Cost of Revenue to Revenue
34.39% 34.06% 31.02% 35.16% 38.01% 40.02% 38.87% 37.76% 39.74% 37.92% 35.70%
SG&A Expenses to Revenue
25.65% 24.18% 22.13% 13.22% 40.80% 41.80% 27.08% 39.29% 34.77% 39.94% 13.09%
R&D to Revenue
24.21% 22.83% 23.43% 29.23% 31.51% 30.30% 28.15% 30.44% 31.37% 31.92% 29.15%
Operating Expenses to Revenue
49.86% 50.18% 0.37% 212.05% 72.30% 74.51% 128.51% 69.73% 66.15% 73.80% 392.29%
Earnings before Interest and Taxes (EBIT)
196 202 745 -1,969 -103 -160 -776 -87 -75 -166 -3,669
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
265 273 815 -1,864 5.00 -51 -668 21 32 -60 -3,566
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
5.35 9.04 9.75 11.91 3.80 3.85 3.68 4.52 5.49 4.82 4.46
Price to Tangible Book Value (P/TBV)
12.97 22.23 29.32 216.58 87.58 106.82 63.54 231.58 169.32 424.08 189.94
Price to Revenue (P/Rev)
2.92 4.91 4.72 3.86 4.85 4.91 4.87 6.64 8.26 6.94 6.39
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
4.30 7.07 6.86 6.86 3.63 3.65 3.45 4.19 5.05 4.45 4.13
Enterprise Value to Revenue (EV/Rev)
3.10 5.08 4.96 4.14 4.94 5.01 4.99 6.80 8.42 7.09 6.54
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
13.43 26.55 31.24 35.29 40.71 47.17 55.58 144.39 162.87 82.92 58.28
Enterprise Value to Free Cash Flow (EV/FCFF)
5.15 9.05 8.85 6.82 43.18 61.15 87.78 34.94 52.83 37.20 39.53
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.84 0.84 0.94 1.56 0.26 0.26 0.25 0.34 0.33 0.41 0.26
Long-Term Debt to Equity
0.63 0.63 0.94 1.04 0.26 0.26 0.25 0.23 0.22 0.23 0.07
Financial Leverage
0.14 0.15 0.20 0.24 0.09 0.09 0.10 0.06 0.06 0.06 0.06
Leverage Ratio
2.00 2.02 2.01 2.23 1.76 1.81 1.69 1.60 1.54 1.58 1.52
Compound Leverage Factor
1.86 1.86 1.94 2.24 1.86 1.90 1.71 1.64 1.60 1.59 1.52
Debt to Total Capital
45.66% 45.60% 48.33% 60.87% 20.63% 20.58% 20.16% 25.45% 25.04% 29.30% 20.55%
Short-Term Debt to Total Capital
11.45% 11.44% 0.00% 20.27% 0.00% 0.00% 0.00% 8.53% 8.39% 13.37% 14.71%
Long-Term Debt to Total Capital
34.21% 34.16% 48.33% 40.60% 20.63% 20.58% 20.16% 16.92% 16.65% 15.93% 5.84%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
54.34% 54.40% 51.67% 39.13% 79.37% 79.42% 79.84% 74.55% 74.96% 70.70% 79.45%
Debt to EBITDA
-3.89 -2.58 -1.82 -0.87 -2.15 -2.24 -2.21 -0.63 -0.54 -0.70 -0.47
Net Debt to EBITDA
-1.47 -1.00 -0.96 -0.48 -0.55 -0.65 -0.82 -0.19 -0.17 -0.18 -0.19
Long-Term Debt to EBITDA
-2.92 -1.93 -1.82 -0.58 -2.15 -2.24 -2.21 -0.42 -0.36 -0.38 -0.13
Debt to NOPAT
-5.09 -3.41 -2.43 -1.20 -1.91 -1.99 -2.06 -0.81 -0.72 -0.93 -0.62
Net Debt to NOPAT
-1.93 -1.32 -1.28 -0.66 -0.49 -0.58 -0.77 -0.25 -0.23 -0.24 -0.25
Long-Term Debt to NOPAT
-3.82 -2.56 -2.43 -0.80 -1.91 -1.99 -2.06 -0.54 -0.48 -0.51 -0.18
Altman Z-Score
2.79 4.03 4.28 1.43 3.56 3.55 3.42 3.96 4.89 3.91 3.46
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.86 1.78 2.43 1.11 1.75 1.66 1.69 1.40 1.42 1.28 0.93
Quick Ratio
1.34 1.26 1.68 0.74 1.18 1.14 1.10 1.00 0.98 0.98 0.63
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
3,113 3,212 4,006 3,412 1,217 1,003 449 3,561 3,763 3,710 1,024
Operating Cash Flow to CapEx
750.00% 1,255.17% 987.50% 258.06% 213.89% 439.22% 308.89% 223.40% 19.23% 167.05% -78.79%
Free Cash Flow to Firm to Interest Expense
124.52 123.54 111.27 170.61 67.63 52.78 23.64 187.44 188.16 463.76 170.68
Operating Cash Flow to Interest Expense
9.60 14.00 8.78 4.00 4.28 11.79 7.32 5.53 0.50 18.38 -8.67
Operating Cash Flow Less CapEx to Interest Expense
8.32 12.88 7.89 2.45 2.28 9.11 4.95 3.05 -2.10 7.38 -19.67
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.53 0.53 0.54 0.50 0.41 0.40 0.42 0.33 0.33 0.33 0.36
Accounts Receivable Turnover
6.50 5.95 6.32 6.41 6.91 6.41 6.78 6.45 6.96 6.95 7.63
Inventory Turnover
2.60 2.66 2.66 2.86 2.97 3.05 2.93 2.97 3.11 3.23 3.30
Fixed Asset Turnover
4.97 4.80 4.69 4.59 4.39 4.29 4.24 4.20 4.20 4.33 4.52
Accounts Payable Turnover
7.16 6.49 7.35 7.60 7.84 6.54 6.61 6.41 6.14 5.16 5.98
Days Sales Outstanding (DSO)
56.13 61.32 57.74 56.95 52.80 56.93 53.86 56.57 52.48 52.51 47.85
Days Inventory Outstanding (DIO)
140.13 136.97 136.99 127.66 122.93 119.77 124.42 122.93 117.24 113.10 110.75
Days Payable Outstanding (DPO)
51.00 56.28 49.66 48.01 46.54 55.79 55.22 56.97 59.46 70.76 61.03
Cash Conversion Cycle (CCC)
145.26 142.00 145.08 136.60 129.19 120.91 123.07 122.53 110.26 94.85 97.57
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
3,121 3,142 3,174 2,676 6,116 6,180 6,454 7,234 7,411 7,297 7,431
Invested Capital Turnover
0.94 0.94 0.91 0.89 0.66 0.67 0.64 0.49 0.48 0.50 0.51
Increase / (Decrease) in Invested Capital
-2,995 -3,038 -3,280 -4,558 -1,295 -1,117 -977 -3,623 -3,808 -3,799 -3,584
Enterprise Value (EV)
13,425 22,223 21,777 18,350 22,188 22,546 22,287 30,321 37,461 32,504 30,711
Market Capitalization
12,672 21,454 20,728 17,110 21,806 22,111 21,731 29,642 36,743 31,806 30,011
Book Value per Share
$14.95 $14.96 $13.34 $9.01 $36.06 $36.18 $37.26 $41.46 $42.36 $41.95 $42.79
Tangible Book Value per Share
$6.17 $6.08 $4.44 $0.50 $1.57 $1.30 $2.16 $0.81 $1.37 $0.48 $1.00
Total Capital
4,358 4,362 4,113 3,670 7,224 7,234 7,387 8,793 8,929 9,334 8,472
Total Debt
1,990 1,989 1,988 2,234 1,490 1,489 1,489 2,238 2,236 2,735 1,741
Total Long-Term Debt
1,491 1,490 1,988 1,490 1,490 1,489 1,489 1,488 1,487 1,487 495
Net Debt
753 769 1,049 1,240 382 435 556 679 718 698 700
Capital Expenditures (CapEx)
32 29 32 31 36 51 45 47 52 88 66
Debt-free, Cash-free Net Working Capital (DFCFNWC)
495 478 459 1.00 1.00 -15 91 111 173 -1.00 23
Debt-free Net Working Capital (DFNWC)
1,732 1,698 1,398 995 1,109 1,039 1,024 1,670 1,691 2,036 1,064
Net Working Capital (NWC)
1,233 1,199 1,398 251 1,109 1,039 1,024 920 942 788 -182
Net Nonoperating Expense (NNE)
-13 -12 21 842 48 62 226 172 -48 50 1,256
Net Nonoperating Obligations (NNO)
753 769 1,049 1,240 382 435 556 679 718 698 700
Total Depreciation and Amortization (D&A)
69 71 70 105 108 109 108 108 107 106 103
Debt-free, Cash-free Net Working Capital to Revenue
11.41% 10.93% 10.46% 0.02% 0.02% -0.33% 2.04% 2.49% 3.89% -0.02% 0.49%
Debt-free Net Working Capital to Revenue
39.94% 38.84% 31.85% 22.47% 24.68% 23.07% 22.93% 37.43% 38.02% 44.42% 22.64%
Net Working Capital to Revenue
28.43% 27.42% 31.85% 5.67% 24.68% 23.07% 22.93% 20.62% 21.18% 17.19% -3.87%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.83 $1.17 $4.43 ($12.48) ($0.77) ($1.08) ($4.64) ($1.44) $0.02 ($0.86) ($23.58)
Adjusted Weighted Average Basic Shares Outstanding
159M 159M 159M 159M 163.61M 162.58M 162.58M 162.58M 162.58M 161.55M 161.55M
Adjusted Diluted Earnings per Share
$0.82 $1.17 $4.42 ($12.48) ($0.77) ($1.08) ($4.64) ($1.44) $0.02 ($0.86) ($23.58)
Adjusted Weighted Average Diluted Shares Outstanding
159M 159M 160M 159M 163.61M 162.58M 162.58M 162.58M 162.58M 161.55M 161.55M
Adjusted Basic & Diluted Earnings per Share
$0.00 $1.17 $0.00 $0.00 $0.00 ($1.08) $0.00 $0.00 $0.00 ($0.86) $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
158.30M 158.40M 158.60M 159.30M 163.92M 163.51M 163.40M 162.89M 162.68M 162.58M 161.86M
Normalized Net Operating Profit after Tax (NOPAT)
118 122 248 174 -78 -114 46 -62 -45 -89 172
Normalized NOPAT Margin
11.34% 11.03% 22.94% 15.67% -7.22% -10.17% 4.13% -5.24% -4.12% -8.20% 15.44%
Pre Tax Income Margin
17.48% 16.85% 66.67% -177.70% -10.13% -14.97% -69.88% -7.57% -7.18% -15.41% -329.33%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
7.84 7.77 20.69 -98.45 -5.72 -8.42 -40.84 -4.58 -3.75 -20.75 -611.50
NOPAT to Interest Expense
4.72 6.69 20.15 -57.30 -4.32 -6.01 -27.78 -3.24 -2.24 -11.11 -426.65
EBIT Less CapEx to Interest Expense
6.56 6.65 19.81 -100.00 -7.72 -11.11 -43.21 -7.05 -6.35 -31.75 -622.50
NOPAT Less CapEx to Interest Expense
3.44 5.58 19.27 -58.85 -6.32 -8.69 -30.15 -5.72 -4.84 -22.11 -437.65
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% -0.08% 0.00% 0.00% 0.00% -0.09% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
-32.71% -9.57% 0.00% 0.00% 0.00% -0.09% 0.00% 0.00% 0.00% 0.00% 0.00%

Frequently Asked Questions About Illumina's Financials

When does Illumina's fiscal year end?

According to the most recent income statement we have on file, Illumina's financial year ends in December. Their financial year 2024 ended on December 29, 2024.

How has Illumina's net income changed over the last 9 years?

Illumina's net income appears to be on an upward trend, with a most recent value of -$1.22 billion in 2024, falling from $458 million in 2015. The previous period was -$1.16 billion in 2023. See Illumina's forecast for analyst expectations on what’s next for the company.

What is Illumina's operating income?
Illumina's total operating income in 2024 was -$833 million, based on the following breakdown:
  • Total Gross Profit: $2.86 billion
  • Total Operating Expenses: $3.69 billion
How has Illumina revenue changed over the last 9 years?

Over the last 9 years, Illumina's total revenue changed from $2.22 billion in 2015 to $4.37 billion in 2024, a change of 96.9%.

How much debt does Illumina have?

Illumina's total liabilities were at $3.93 billion at the end of 2024, a 10.0% decrease from 2023, and a 117.5% increase since 2015.

How much cash does Illumina have?

In the past 9 years, Illumina's cash and equivalents has ranged from $735 million in 2016 to $2.04 billion in 2019, and is currently $1.13 billion as of their latest financial filing in 2024.

How has Illumina's book value per share changed over the last 9 years?

Over the last 9 years, Illumina's book value per share changed from 12.63 in 2015 to 14.96 in 2024, a change of 18.5%.



This page (NASDAQ:ILMN) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners